본문 바로가기

Introduction of
CHA Medical Group

To become the No.1 Global Biomedical Group by translating findings in our research into medical practice.

CHA Medical Group was founded in 1960 with the opening of CHA Obstetrics & Gynecology Clinic in Seoul, Korea. In 1984, Chairman Kwang-yul Cha established CHA Gangnam Medical Center, which was Korea's first specialized hospital. During the 1980s, CHA Gangnam Medical Center and CHA Fertility Center were pioneers in the field of fertility medicine, which had not been developed in Korea. As CHA group's remarkable achievements were introduced in Time Magazine and other U.S. publications, CHA Medical Group began to develop an international reputation for its world-class fertility treatments and advances in reproductive medicine. During the 1990s, CHA Medical Group was the first in Korea to export its fertility technology to the U.S., by establishing CHA-Columbia Fertility Center at Columbia University in New York City.

CHA Medical Group founded CHA Bundang Medical Center in 1995 and in 1999, CHA Gumi Medical Center and CHA University and School of Medicine. It continued its expansion in the U.S. by acquiring Hollywood Presbyterian Medical Center in 2004. CHA group has also established a foundation for the development of blockbuster cell therapies by forming a biomedicine research institute known as "CHA Biotech".
In 2010, it opened the unprecedented Chaum Life Center in Gangnam, Seoul, which has been hailed as the model for the future of health care.

By establishing Total Cell Clinic TOKYO(TCC TOKYO) in Japan in 2014, CHA Medical Group became the first Korean medical institution to penetrate medical circles in both the U.S. and Japan. With the goal of becoming the leader in the field of biomedicine,
CHA group created the futuristic medical research institution "CHA Bio Complex" for the development of new drugs and to facilitate cooperation among industrial, academic and research circles worldwide. CHA Medical Group has established itself as a pioneer in the field of medicine through innovative ideas and has continued to strengthen its status as a premiere global healthcare group.

Introduce of CHA Medical Group

History of CHA Medical Group

The work of studying the mysteries of life, human life more mysterious than the universe, to discover ground-breaking treatments in maintaining a healthy life has been the mission upheld by CHA Group for a half-century, and the faithful path of a medical group serving humankind.
Now we strive toward a new, greater ideal of becoming a world-class biomedical group that brings happiness into the life of humanity

World’s first successful completion ofthe adult somatic stem cell cloningby CHA Group becomes the history of life science itself.
Our endless challenge toward the achievement of well-aging for mankind will never cease.

CHA Group, which began its new challenge toward being a world-class biomedical group, will change the global medical paradigm and open up a new era of life science.
CHA Bio Complex, a future of bio research experience spanning a half-century with medical and scientific vision and results.
With the hospital as its platform, CHA Bio Complex will research, communicate, and fuse countless methods that can cure disease through synergetic collaboration with universities, research institutes, and biomedical companies to take its place in the world as a stem-cell research hub.
CHA Group is building a network of hospitals affiliated with CHA University Medical Schools throughout major cities in South Korea. The futuristic life center, “Chaum”, is opening a new chapter in “Total Healthcare” by merging Eastern and Western medicine that comprehensively cares for the health of body and mind.
Starting with Gangnam CHA Medical Center at the helm, the history and present hallmark of women’s medicine in Korea, Bundang CHA Medical Center, a research centered general hospital gaining fame, and the hospitals providing the most cutting edge medical services to local communities, Daegu CHA Medical Center and Gumi CHA Medical Center, make up the key network stations in South Korea.
Overseas, the network extends toHPMC is the biggest privately owned hospital in LA, CA and to Japan with Total Cell Clinic TOKYO(TCC TOKYO), with goals to push forward into China, Russia, and other regions.

CHA University, a university unique in the world featuring three core connected institutions of research, hospitals, and business.
From its inception, CHA University has provided generous support through programs such as full scholarships to its entire medical faculty in order to cultivate skilled medical professionals.
CHA Group, currently operate 10 biomedical related companies including 3 companies that went publictaking on the endless challenge of seeking out innovative ways for humankind to manage health and youth.
The work of developing cures and solutions for incurable diseases through stem cell research, bringing new hope for humankind through achievements in genomic research and infertility, seeking out groundbreaking methods able to manage health and youth, and to bring new hope to humanity through the development of biomedical and biotech products.
This is why CHA Group operates companies related to biotechnology and it is this mindset that compels us to make the spirit of having “respect for life” a reality.

Epilogue

Birth, which by itself illustrates the mystery of human life…
Throughout the ever growing life of humanity, know that CHA Group’s biotechnology for aging well is with you every step of the way.

This is the direction of our future and the reason that the world will regard CHA Group as a global medical leader.

A flagship of biotechnology. CHA Group!